IRC
BIO icon

Investors Research Corp’s Bio-Rad Laboratories Class A BIO Stock Holding History

Investors Research Corp’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-4
Closed -$1.17K – 794
2026
Q2 		$1.17K Hold
4
– – ﹤0.01% 727
2026
Q1 		$1.11K Buy
+4
New +$1.15K ﹤0.01% 761

Other funds holding BIO

GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.01B AUM 28.81% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GWM
Gilpin Wealth Management Denver, Colorado $148M AUM 25.13% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
GBT
Grove Bank & Trust Miami, Florida $1.01B AUM 19.76% 1-Year Est. Return

Investors Research Corp's BIO Position: Q3 2026 in Review

Investors Research Corp sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2026, closing a stake of 4 shares — an estimated $1.17K sold.

Investors Research Corp first reported a position in BIO in Q1 2026 and held it in 2 quarters. The position peaked at $1.17K in Q2 2026. 10 funds tracked by Wall St. Rank hold BIO as of Q3 2026.

  • Investors Research Corp reported no remaining Bio-Rad Laboratories Class A position as of Q3 2026 after selling out during the quarter.
  • Investors Research Corp sold 4 Bio-Rad Laboratories Class A shares in Q3 2026, an estimated $1.17K.
  • Investors Research Corp first reported a position in Bio-Rad Laboratories Class A in Q1 2026 and held it in 2 quarters.
  • Investors Research Corp's Bio-Rad Laboratories Class A position peaked at $1.17K in Q2 2026.
  • 10 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2026.

Based on Investors Research Corp's 13F filing for Q3 2026, filed 7 Oct 2026.